The abstract is read at the publisher; the summary is JClub's.
In JAX #038212 humanized-apical-domain TfR1 mice, NanoNewron NewroBus anti-TNF constructs NN-841 and NN-843 showed no detectable 24-hour brain parenchymal-fraction signals, unlike Cyagen models.
- Why it matters: BBB delivery readouts can be misleading because TfR1 humanization design varies across strains, creating false-negative outcomes that complicate platform evaluation.
- What they did: Thirty mice received intravenous injections of NN-841 or NN-843 and were assessed 24 h later; brain parenchymal-fraction signals were compared across JAX #038212, Cyagen C001584, Cyagen C001860, and wild-type controls.
- The result: Serum levels were measurable in all groups with rank order Cyagen-CDS>Cyagen-HU>wild type >JAX, and mean CDS-to-JAX serum ratios were approximately 13-fold, implying model choice affects apparent BBB delivery.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.